Nanotechnology
Overview
Nanotechnology holds promise in the field of Amyotrophic Lateral Sclerosis (ALS) research and potential therapeutic interventions.
According to Wang, Rayner, Chung, Shi and Liang (2020), significant progress has been made in nanotechnology-based strategies of ALS.
While specific applications are still in early stages of exploration there is potential for new strategies for nanotechnology to continue to ALS treatment.
While these potential applications are promising, it's important to note that nanotechnology in ALS is still an area of active research, and practical clinical applications may take time to develop. Collaborative efforts between nanotechnology experts and ALS researchers are ongoing to harness the full potential of nanoscience in addressing the challenges posed by ALS.
Learn More
National Nanotechnology Initiative
Sources
Wang, G. Y., Rayner, S. L., Chung, R., Shi, B. Y., & Liang, X. J. (2020). Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis. Materials today. Bio, 6, 100055. https://doi.org/10.1016/j.mtbio.2020.100055
Mazibuko, Z., Choonara, Y. E., Kumar, P., Du Toit, L. C., Modi, G., Naidoo, D., & Pillay, V. (2015). A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. Journal of pharmaceutical sciences, 104(4), 1213–1229. https://doi.org/10.1002/jps.24322